Risk management according to ISO 14971.
We assist medtech and pharmaceutical companies in establishing, reviewing, and continuously maintaining their risk management systems—as the foundation for MDR/IVDR compliance and product safety.
Why choosing a method alone won't improve your risk analysis.
When it comes to risk analysis, people often ask only about the method (FMEA, FTA). But the real challenge lies in the analytical interpretation:
Methods such as PHA, FTA, ETA, or FMEA are established tools, but they are not synonymous with hazard analysis as defined by ISO 14971. A failure mode is not automatically a hazard. A top event is not automatically a risk. There is almost always a critical translation step between the output of the FMEA and the risk dossier. This is precisely where most weaknesses arise.
Our risk management services.
We develop systems that are compliant with regulatory standards (ISO 14971) and easy to use in everyday practice.
Risk Analysis & Risk Assessment
Risk Management File & Lifecycle
Post-Production Risk Review
Risk Management for Software as a Medical Device (SaMD)
Risk Management for AI (AI Act)
Learn how to seamlessly integrate the new safety and cybersecurity requirements of the EU AI Act into your existing ISO 14971 QMS.
Download the white paper for free →Frequently Asked Questions About Risk Management.
What is ISO 14971, and why is it mandatory?
What is an FMEA, and when is it used?
How is risk management linked to clinical evaluation?
What has changed with ISO 14971:2019?
Additional expertise regarding ISO 14971.
Compliance with risk management standards saves lives.
Turn methodology into real product safety. We seamlessly integrate your risk management documentation with clinical evaluation and post-market surveillance.